Clinical Trial Update: The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir [Phase 3]

View source ↗

Summary

Phase 3 study evaluating injectable cabotegravir for HIV pre-exposure prophylaxis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: Evandro Chagas National Institute of Infectious Disease | Conditions: HIV Infections | Phase 3 | Status: RECRUITING